Jing Zhou

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Y. Hu, Ying Cheng, Yi-long Wu, 2020, Frontiers in Oncology.

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

Qinghua Zhou, Yiping Zhang, Z. Guan, 2005, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Early detection of lung cancer by using an autoantibody panel in Chinese population

F. Hirsch, Hui Yu, H. Cai, 2018, Oncoimmunology.

Long‐term results of a randomized, double‐blind, and placebo‐controlled phase III trial: Endostar (rh‐endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non‐small cell lung cancer

Qiang Chen, Wei Liu, Yan Sun, 2013, Thoracic cancer.